August 27, 2015
Novo Nordisk Pharma received approval on August 24 for an additional pediatric dosage for its long-acting insulin analogue Tresiba FlexTouch and Penfill (recombinant insulin degludec), it said on August 26. Tresiba is Japan’s first long-acting insulin analogue indicated for children...read more